| 000 | 01652 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515040509.0 | ||
| 264 | 0 | _c20061024 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.105.608869 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrice, Jack F | |
| 245 | 0 | 0 |
_aB-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. _h[electronic resource] |
| 260 |
_bCirculation _cSep 2006 |
||
| 300 |
_a1063-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 | _aOutpatients |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSystole |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xblood |
| 700 | 1 | _aThomas, Anne K | |
| 700 | 1 | _aGrenier, Michelle | |
| 700 | 1 | _aEidem, Benjamin W | |
| 700 | 1 | _aO'Brian Smith, E | |
| 700 | 1 | _aDenfield, Susan W | |
| 700 | 1 | _aTowbin, Jeffrey A | |
| 700 | 1 | _aDreyer, William J | |
| 773 | 0 |
_tCirculation _gvol. 114 _gno. 10 _gp. 1063-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.105.608869 _zAvailable from publisher's website |
| 999 |
_c16525588 _d16525588 |
||